ImmunoPrecise Antibodies Ltd.

TSXV:IPA Stok Raporu

Piyasa değeri: CA$162.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

ImmunoPrecise Antibodies Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Jennifer Bath

İcra Kurulu Başkanı

CA$1.9m

Toplam tazminat

CEO maaş yüzdesi34.9%
CEO görev süresi4.8yrs
CEO sahipliği0.4%
Yönetim ortalama görev süresi1.3yrs
Yönetim Kurulu ortalama görev süresi4.5yrs

Son yönetim güncellemeleri

Recent updates

We Think ImmunoPrecise Antibodies (CVE:IPA) Needs To Drive Business Growth Carefully

Oct 20
We Think ImmunoPrecise Antibodies (CVE:IPA) Needs To Drive Business Growth Carefully

Earnings Update: ImmunoPrecise Antibodies Ltd. (CVE:IPA) Just Reported And Analysts Are Boosting Their Estimates

Dec 23
Earnings Update: ImmunoPrecise Antibodies Ltd. (CVE:IPA) Just Reported And Analysts Are Boosting Their Estimates

Is ImmunoPrecise Antibodies (CVE:IPA) Using Debt In A Risky Way?

Nov 25
Is ImmunoPrecise Antibodies (CVE:IPA) Using Debt In A Risky Way?

CEO Tazminat Analizi

Jennifer Bath'un ücretlendirmesi ImmunoPrecise Antibodies'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jul 31 2022n/an/a

-CA$23m

Apr 30 2022CA$2mCA$649k

-CA$17m

Jan 31 2022n/an/a

-CA$17m

Oct 31 2021n/an/a

-CA$15m

Jul 31 2021n/an/a

-CA$10m

Apr 30 2021CA$2mCA$503k

-CA$7m

Jan 31 2021n/an/a

-CA$3m

Oct 31 2020n/an/a

-CA$3m

Jul 31 2020n/an/a

-CA$3m

Apr 30 2020CA$673kCA$488k

-CA$5m

Jan 31 2020n/an/a

-CA$8m

Oct 31 2019n/an/a

-CA$8m

Jul 31 2019n/an/a

-CA$9m

Apr 30 2019CA$1mCA$505k

-CA$8m

Jan 31 2019n/an/a

-CA$6m

Oct 31 2018n/an/a

-CA$6m

Jul 31 2018n/an/a

-CA$5m

Apr 30 2018CA$65kCA$65k

-CA$5m

Tazminat ve Piyasa: Jennifer's total compensation ($USD1.39M) is above average for companies of similar size in the Canadian market ($USD178.89K).

Tazminat ve Kazançlar: Jennifer's compensation has been consistent with company performance over the past year.

CEO

Jennifer Bath

4.8yrs

Görev süresi

CA$1,856,482

Tazminat

Dr. Jennifer Lynne Bath, Ph D, has been the Chief Executive Officer and President of ImmunoPrecise Antibodies Ltd. since February 21, 2018.Dr. Bath served as the Global Director of Client Relations at Ald...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Jennifer Bath
CEO, President & Non-Independent Director4.8yrsCA$1.86m0.44%
CA$ 707.3k
Brad McConn
Chief Financial Officerless than a yearCA$432.71k0.032%
CA$ 52.0k
Ilse Roodink
Chief Scientific Officer1.3yrsCA$514.16k0.013%
CA$ 21.7k
David Orton
Chief Operating Officer5.7yrsVeri yokVeri yok
Carla Dahl
Vice President of Marketing1.3yrsVeri yok0.040%
CA$ 65.0k
Barry Duplantis
Vice President of Client Relationsno dataVeri yok0.0048%
CA$ 7.8k

1.3yrs

Ortalama Görev Süresi

Deneyimli Yönetim: IPA's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Jennifer Bath
CEO, President & Non-Independent Director4.5yrsCA$1.86m0.44%
CA$ 707.3k
James Kuo
Independent Chairman of the Board5.9yrsCA$130.84k0.10%
CA$ 162.5k
Gregory Smith
Independent Director6.2yrsCA$95.66k0.17%
CA$ 282.7k
Guy Champagne
Member of Advisory Board4.3yrsCA$55.00kVeri yok
Robert Burke
Independent Director4.9yrsCA$87.99k0.12%
CA$ 201.5k
Dion Neame
Member of Strategic Advisory Board1.5yrsVeri yokVeri yok
Anna Pettersson
Independent Directorless than a yearCA$75.55kVeri yok

4.5yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: IPA's board of directors are considered experienced (4.5 years average tenure).